EDITORIAL / CORRESPONDENCE
Contact the Wolverine Buy Record
For corrections, source suggestions, and editorial questions about the BPC-157 TB-500 digest.
Editorial correspondence
This is the contact surface for the BPC-157 TB-500 editorial record. We welcome corrections, additional peer-reviewed sources we may have missed, and questions about how a particular finding is summarized. If you believe a citation is misread or a regulatory detail is out of date, tell us and point to the source — accuracy of the record is the whole point of the project.
What we cannot help with: we are not a clinic and do not give medical advice, we do not manufacture or sell either peptide, and we cannot direct anyone to a place to obtain the blend or its constituents. Messages asking where to buy, how to dose for personal use, or how to obtain a restricted substance outside the lawful framework will not receive that information.
Send a note
Use the form below to reach the editors. Include a link to any study or document you are referencing so we can verify it against the record. We read every note, though we cannot promise an individual reply to each one.
General information on this site describes the regulatory landscape and the published research; it is not medical or legal advice, and nothing here is an offer to sell or supply any substance.